Your email has been added to our waiting list and we will send an invite to you as soon as possible. Thank you for your patience.
In the meantime, if you happen to run a blog, our newly launched Blog Enhancement Suite can utilize the immense power of community to help you get more audience, engagement, content, and revenue with your own embeddable community! It will breathe new life into your blog and can automate many of the tedious tasks that come with the territory, so you can focus more on what matters most... writing.
Help spread the word about Snapzu:
Let others know about Snapzu by tweeting about us. We appreciate every mention!
FDA approves GSK's RSV vaccine for older adults, world's first shot against virus
The Food and Drug Administration on Wednesday approved an RSV vaccine produced by GlaxoSmithKline
for use on adults ages 60 and older. The approval, the first ever globally by a regulatory body for an RSV vaccine, is a decisive victory for GSK in a race against drugmakers Pfizer and Moderna to bring to market a shot that targets the respiratory syncytial virus.